Interactions between inducible nitric oxide synthase and heme activated in inflammation. Such enzymes include iNOS, oxygenase-1 in glomerulonephritis.
NO derived from iNOS activation and reactive oxygen the HO-1 inducer hemin. Glomerular HO-1 levels were assessed by Western blot analysis. iNOS activity was assessed by calcumetabolites derived from activation of cytochrome P450 lating conversion of l-arginine to l-citrulline.
monoxygenases during NADPH-dependent electron trans-

Results. iNOS inhibition reduced glomerular HO-1 levels
fer. An overall anti-inflammatory/antioxidant effect can without altering the inflammatory response to anti-GBM antithus be expected as a result of HO-1 activation. Supportbody induced injury. Induction of HO-1 reduced glomerular ing this hypothesis, it was shown that HO-1 induction iNOS activity.
Conclusions. In anti-GBM nephritis iNOS up-regulates HO-1 protects from chemically induced inflammation in the presumably via high output NO production. Suprainduction of pleural cavity [5] , and protects renal tubules from myo-HO-1 attenuates iNOS activity. This negative feedback interacglobin or hemoglobin induced injury [6] . It was further tion points to HO-1 as a target for pharmacologic manipulation
shown that HO-1 induction prolongs survival of cardiac to reduce activity of prooxidant heme containing enzymes such xenografts in mice and protects against chronic rejection as iNOS. [7, 8] . Finally, two independent studies demonstrated that HO-1 induction attenuates proteinuria in the rat model of anti-GBM nephritis [2, 9] . The mechanism of enhanced In experimental glomerulonephritis, as exemplified in HO-1 expression in glomerulonephritis is unknown. In the model of anti-glomerular basement membrane (antiprevious studies we reported that NO derived from NO GBM) antibody induced nephritis, there is enhanced exdonors or from iNOS activation by cytokines stimulates pression and enzyme activity of the inducible nitric oxide HO-1 expression and activity in glomerular mesangial synthase (iNOS) and of heme oxygenase-1 (HO-1) in glocells [10] . This, and the observation that iNOS and HO-1 meruli [1, 2] . iNOS activation results in a sustained high are coactivated within nephritic glomeruli, prompted us output production of nitric oxide (NO), which can cause to explore regulatory interactions between these two enoxidative injury either on its own or by interacting with zyme systems. We employed the rat model of anti-GBM the superoxide anion to form the relatively stable pronephritis to explore whether iNOS activation stimulates oxidant peroxynitrite (ONOO Ϫ ) [3] . HO-1 is the induc-HO-1 expression and whether HO-1 induction attenuible isoform of heme oxygenase. It catalyzes the NADPH, ates iNOS activity. O 2 and cytochrome P450 reductase-dependent oxidation of heme to carbon monoxide, iron and biliverdin, which is reduced to bilirubin by biliverdin reductase [4] . Heme METHODS is a key constituent of a number of enzymes that are
Development of anti-GBM nephritis
Male Lewis rats weighing 175 to 200 g were immunized ately before use by dissolving in 0.1N NaOH adjusted to pH 7.4 with 0.1N HCl, and further diluted in saline for subcutaneous injections.
Western blot analyses of HO-1 and ED 1 protein levels in glomeruli
These analyses assessed glomerular levels of HO-1 and of the rat macrophage marker ED 1 as an index of the extent of infiltration of nephritic glomeruli by macrophages. Preparation of glomerular protein lysates and electrophoretic transfer of proteins were performed as previously described [9, 10] . Membranes were incubated either with rabbit polyclonal antibody against rat HO-1 (1:1000 dilution) obtained from StressGen Biotechnoloof 0.5 mL. Seven days after this immunization, animals gies (Vancouver, British Columbia, Canada), or with antiwere injected in the tail vein with two subnephritogenic ED 1 antibody (Serotec, Westbury, NY, USA), washed doses (0.3 mL/100 g body wt given 24 hours apart) of rabthoroughly and incubated with anti-rabbit horseradish bit immune serum raised against rat particulate GBM.
peroxidase-conjugated second antibody. Detection of This protocol results in heavy proteinuria and accelersignal used an enhanced chemiluminescence detection ated onset of glomerular infiltration by macrophages, kit (Amersham, Arlington Heights, IL, USA). crescent formation, and scarring [9] . Animals were nephrectomized 24 hours after the second injection of antiiNOS enzyme activity rat GBM serum or of nonimmune rabbit serum (conActivity of iNOS in glomerular lysates was determined trols) and glomeruli were isolated by differential sieving by calculating conversion of l-[ used t test statistics for unpaired observations. P Ͻ 0.05 Induction of HO-1 was considered significant. We employed the HO-1 inducer hemin (Ferriprotoporphyrin IX chloride; Sigma). Animals were injected RESULTS subcutaneously with hemin, 30 mol/kg body wt, or with iNOS inhibition reduces glomerular HO-1 levels saline vehicle 24 hours before the first and second injecPre-treatment of animals with anti-GBM nephritis tion of anti-GBM serum or of rabbit nonimmune serum. A solution of hemin (10 mmol/L) was prepared immediwith L-NIL reduced urine nitrite excretion to 88.25 Ϯ 9.39 mol per mg creatinine compared to a value of regulates glomerular HO-1 in anti-GBM nephritis. Thus, pretreatment with the selective iNOS inhibitor, L-NIL, 839.51 Ϯ 315.70 in nephritic animals not pretreated with in doses sufficient to reduce urine nitrite excretion, atten-L-NIL (P Ͻ 0.05).
uated glomerular HO-1 protein levels. There was no ef- Figure 1 shows a Western blot analysis of ED 1 and fect on extent of glomerular infiltration by macrophages HO-1 proteins in protein lysates prepared from glomerassessed as glomerular levels of the ED 1 marker (Fig. uli isolated from animals that received anti-GBM serum 1). This indicates that the reduction in HO-1 levels obor from controls that received non-immune serum. In this served in L-NIL treated animals was due to iNOS inhibiexperiment, two animals received non-immune serum tion rather than to an alteration of the inflammatory (NIS) (lanes 1 and 2 in the upper and lower panels), response to anti-GBM antibody-induced injury that three animals received anti-GBM serum (lanes 3, 4, 5 in could have occurred as a result of the L-NIL treatment. the upper and lower panels) and three animals received
In its capacity as the rate-limiting enzyme of heme anti-GBM serum and L-NIL treatment (lanes 6, 7, 8 in degradation, HO-1 reduces cellular heme levels thereby the upper and lower panels). As expected, ED1 levels limiting availability of heme for synthesis or enzyme were higher in nephritic glomeruli (upper panel; lanes activity of heme containing enzymes such as iNOS. activity (Fig. 3) . This supports the presence of a negative regulatory interaction between HO-1 and iNOS whereby Suprainduction of HO-1 reduces glomerular induction of HO-1 reduces iNOS activity.
iNOS activity
In summary, our studies demonstrate a negative feedHemin treatment prior to administration of anti-GBM back interaction between iNOS and HO-1 in nephritic serum increased HO-1 protein level in glomeruli of neglomeruli whereby iNOS activation up-regulates HO-1, phritic animals (Fig. 2, lane 2) compared to the level in presumably via a sustained high output NO production, glomeruli of nephritic animals that were not treated with and HO-1 induction attenuates iNOS activity. These obhemin (Fig. 2, lane 1) . In nephritic animals, iNOS enzyme servations point to HO-1 as a potential target for pharmaactivity in glomeruli was markedly increased (Fig. 3) .
cologic manipulation in order to enhance its expression/ activity in glomerulonephritis. This may have a beneficial Hemin pre-treatment significantly reduced glomerular effect by reducing activity of proinflammatory/prooxidant iNOS activity (Fig. 3) .
heme-containing enzymes such as iNOS, cyclooxygenase and the cytochrome P450 monooxygenases. present studies demonstrate that iNOS activation up-
